Drugmakers fined $8 million by Shanghai regulator for price fixing, market allocation
MLex Summary: Two Chinese drugmakers were fined a combined 57 million yuan ($8.3 million) by the Shanghai antitrust regulator for price fixing and market allocation involving the sale of fluorouracil injections....To view the full article, register now.
Already a subscriber? Click here to view full article